Good news for people with clotting disorder | Science News



Support credible science journalism.

Subscribe to Science News today.


Good news for people with clotting disorder

12:42pm, January 9, 2007

Patients with the bleeding disorder called immune thrombocytopenic purpura (ITP) harbor antibodies that sabotage production of the platelets responsible for proper blood clotting. ITP patients often feel fatigued and bruise so easily that they look battered. The most common treatment is a regimen of harsh steroids to suppress the rogue antibodies. Some patients have their spleens removed to relieve the aberrant immune reaction. These therapies leave patients susceptible to serious medical problems.

Scientists now report that ITP patients may soon be able to boost their platelet production with fewer side effects, thanks to two oral drugs that are nearing the end of clinical trials. Two other drugs in earlier testing also show promise, researchers reported in December 2006 at a meeting of the American Society of Hematology in Orlando, Fla.

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content